GBIM - GlobeImmune, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201512/31/201412/31/201312/31/2012
Total Revenue6,457.7335,966.38122,518.36914,641.606
Cost of Revenue2,648.064,992.2129,024.2510,033.04
Gross Profit3,809.673974.16913,494.1194,608.566
Operating Expenses
Research Development1,835.0782,221.2041,860.3781,701.511
Selling General and Administrative4,554.1654,276.9183,174.7695,948.066
Non Recurring----
Others----
Total Operating Expenses9,224.63811,785.49914,830.67718,608.09
Operating Income or Loss-2,766.905-5,819.1187,687.692-3,966.484
Income from Continuing Operations
Total Other Income/Expenses Net--10,441.8081,904.7721,951.74
Earnings Before Interest and Taxes-2,766.905-5,819.1187,687.692-3,966.484
Interest Expense--3,890.662-3,890.662-3,890.662
Income Before Tax-2,766.905-16,260.9269,592.464-2,014.744
Income Tax Expense--115.765-
Minority Interest----
Net Income From Continuing Ops-2,766.905-16,260.9269,476.699-2,014.744
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,766.905-16,260.9269,476.699-2,014.744
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,766.905-23,434.827-3,408.442-14,118.995